{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T11:47:33Z","timestamp":1768736853875,"version":"3.49.0"},"reference-count":67,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2010,8,5]],"date-time":"2010-08-05T00:00:00Z","timestamp":1280966400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction"],"published-print":{"date-parts":[[2010,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p><jats:bold>Aims\u2003<\/jats:bold> To help counter problems related to methamphetamine, Mexico has implemented interventions targeting pseudoephedrine and ephedrine, the precursor chemicals commonly used in the drug's synthesis. This study examines whether the interventions impacted methamphetamine treatment admissions\u2014an indicator of methamphetamine consequences.<\/jats:p><jats:p><jats:bold>Design\u2003<\/jats:bold> Quasi\u2010experiment: autoregressive integrated moving average (ARIMA)\u2010based intervention time\u2013series analysis. Interventions: precursor chemical restrictions implemented beginning November 2005; major rogue precursor chemical company closed (including possibly the largest single drug\u2010cash seizure in history) March 2007; precursor chemicals banned from Mexico (North America's first precursor ban) August 2008.<\/jats:p><jats:p><jats:bold>Settings\u2003<\/jats:bold> Mexico and Texas (1996\u20132008).<\/jats:p><jats:p><jats:bold>Measurements\u2003<\/jats:bold> Monthly treatment admissions for methamphetamine (intervention series) and cocaine, heroin and alcohol (quasi\u2010control series).<\/jats:p><jats:p><jats:bold>Findings\u2003<\/jats:bold> The precursor restriction was associated with temporary methamphetamine admissions decreases of 12% in Mexico and 11% in Texas. The company closure was associated with decreases of 56% in Mexico and 48% in Texas; these decreases generally remained to the end of the study period. Neither intervention was associated with significant changes in the Mexico or Texas quasi\u2010control series. The analysis of Mexico's ban was indeterminate due largely to a short post\u2010ban series.<\/jats:p><jats:p><jats:bold>Conclusions\u2003<\/jats:bold> This study, one of the first quasi\u2010experimental analyses of an illicit\u2010drug policy in Mexico, indicates that the country's precursor interventions were associated with positive impacts domestically and in one of the Unites States' most populous states\u2014Texas. These interventions, coupled with previous US and Canadian interventions, amount to a new, relatively cohesive level of methamphetamine precursor control across North America's largest nations, raising the possibility that the impacts found here could continue for an extended period.<\/jats:p>","DOI":"10.1111\/j.1360-0443.2010.03068.x","type":"journal-article","created":{"date-parts":[[2010,8,6]],"date-time":"2010-08-06T15:17:13Z","timestamp":1281107833000},"page":"1973-1983","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Mexico's methamphetamine precursor chemical interventions: impacts on drug treatment admissions"],"prefix":"10.1111","volume":"105","author":[{"given":"James K.","family":"Cunningham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ietza","family":"Bojorquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Octavio","family":"Campollo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lon\u2010Mu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane Carlisle","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,8,5]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.18356\/7790665d-en"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1080\/10826080500411478"},{"key":"e_1_2_8_4_2","volume-title":"Encuesta Nacional De Adicciones 2008 [National Survey on Addictions 2008]","author":"Instituto Nacional de Salud P\u00fablica","year":"2008"},{"key":"e_1_2_8_5_2","first-page":"1","article-title":"Demand of drugs: Mexico in the international perspective","volume":"26","author":"Medina\u2010Mora M. E.","year":"2003","journal-title":"Salud Mental"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(06)80014-1"},{"key":"e_1_2_8_7_2","first-page":"507","article-title":"La encuesta nacional de adicciones de M\u00e9xico [National survey on addictions of Mexico]","volume":"32","author":"Tapia\u2010Conyer R.","year":"1990","journal-title":"Salud Publica Mex"},{"key":"e_1_2_8_8_2","first-page":"95","article-title":"Drug trafficking: Mexico and Columbia in comparative perspective","volume":"35","author":"Lupsha P. A.","year":"1981","journal-title":"J Int Affairs"},{"key":"e_1_2_8_9_2","volume-title":"Methamphetamine Precursor Chemical Control in the 1990s","author":"Haislip G. R.","year":"1996"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02458.x"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2007.12.006"},{"key":"e_1_2_8_12_2","unstructured":"Secretaria de la Func\u00edon P\u00fablica (SFP).Informe de Rendici\u00f3n de Cuentas de la Administraci\u00f3n 2000\u20132006. Clave Presupuestaria SOO. Nombre: Comisi\u00f3n Federal para la Protecci\u00f3n contra Riegos Sanitarios [Report on Accountability of Management 2000\u20132006. Budget key SOO. Name: Federal Commission for Protection against Health Risks]. M\u00e9xico DF: SFP;2006."},{"key":"e_1_2_8_13_2","first-page":"29","volume-title":"Report of the International Narcotics Control Board for 2005","author":"International Narcotics Control Board","year":"2006"},{"key":"e_1_2_8_14_2","unstructured":"TandyK. P.Statement of Karen P. Tandy Administrator Drug Enforcement Administration U.S. Department of Justice. Regarding International Meth Trafficking. Before the Senate Foreign Relations Committee Subcommittee on International Economic Policy Export and Trade Promotion and Subcommittee on Western Hemisphere Peace Corps and Narcotics Affairs 21 June 2006. Washington DC: Drug Enforcement Administration;2006."},{"key":"e_1_2_8_15_2","volume-title":"Control de la Pseudoefedrina en M\u00e9xico [Control of Pseudoephedrine in Mexico]","author":"Comisi\u00f3n Federal para la Protecci\u00f3n contra Riesgos Sanitarios (COFEPRIS)","year":"2007"},{"key":"e_1_2_8_16_2","volume-title":"Convenio de Concertaci\u00f3n de Acciones para un Efectivo Control de Medicamentos que Contienen Pseudoefedrina [Agreement of Concerted Actions for Effective Control of Drugs Containing Pseudoephedrine]","author":"Comisi\u00f3n Federal para la Protecci\u00f3n contra Riesgos Sanitarios (COFEPRIS)","year":"2006"},{"key":"e_1_2_8_17_2","unstructured":"Cordova VillalobosJ. A.Entrevista al Secretario de Salud Jos\u00e9\u00c1ngel C\u00f3rdova Villalobos al termino de XXII Congreso Internacional de Farmacias [Interview with Secretary of Health Jose Angel Cordova Villalobos following the XXII International Congress of Pharmacists]. M\u00e9xico DF: Secretar\u00eda de Salud;2007."},{"key":"e_1_2_8_18_2","first-page":"21","article-title":"Pseudoefedrina: se proh\u00edbe su comercializaci\u00f3n en M\u00e9xico [Pseudoephedrine: commercialization is prohibited in Mexico]","volume":"11","author":"F\u00e1rmacos","year":"2008","journal-title":"F\u00e1rmacos"},{"key":"e_1_2_8_19_2","unstructured":"Procuradur\u00eda General de la Rep\u00fablica (PGR).Bolet\u00edn 121\/07. Los 205 millones de d\u00f3lares asegurados por la Polic\u00eda Federal producto de las transacciones ilegales de pseudoefedrina con empresas de China [Bulletin 121\/07. 205 million dollars secured by the Federal Police a product of illegal pseudoephedrine transactions with companies in China]. M\u00e9xico DF: PGR;2007."},{"key":"e_1_2_8_20_2","unstructured":"McCampbellC. A.Statement by Christy A. McCampbell Deputy Assistant Secretary Bureau for International Narcotics and Law Enforcement Affairs U. S. Department of State. Testimony before the Senate Finance Committee September 18 2007. Bilateral and Multilateral Efforts to Combat the International Production and Trafficking of Methamphetamine. Washington DC: US Government Printing Office;2007:86\u201395."},{"key":"e_1_2_8_21_2","unstructured":"Procuradur\u00eda General de la Rep\u00fablica (PGR).Bolet\u00edn 338\/07. La PGR tiene un caso jur\u00eddico s\u00f3lido y contundente en contra de Zhenli Ye Gon por delitos contra la salud en varias modalidades; delincuencia organizada; posesi\u00f3n de armas de fuego y cartuchos reservados para las fuerzas armadas; y operaciones con recursos de procedencia il\u00edcita. [Bulletin 338\/07. The PGR has a solid and overwhelming legal case against Zhenli Ye Gon for different types of crimes against health; organized crime possession of firearms and cartridges reserved for the Armed Forces and illegal procedural operations. M\u00e9xico DF: PGR;2007."},{"key":"e_1_2_8_22_2","unstructured":"Comisi\u00f3n Federal para la Protecci\u00f3n contra Riesgos Sanitarios (COFEPRIS).La COFEPRIS present\u00f3 ante la PGR 41 denuncias penales por 161 permisos sanitarios de importaci\u00f3n ap\u00f3crifos [COFEPRIS filed before the PGR 41 criminal complaints due to 161 fraudulent importation health permits]. M\u00e9xico DF: COFEPRIS;2007."},{"key":"e_1_2_8_23_2","first-page":"31","article-title":"Acuerdo por el que se establecen medidas de protecci\u00f3n en material de salud humana para prevenir el uso y consumo de pseudoefedrina y efedrina. [General Health Council. Agreement establishing protective measures for human health to prevent the use and consumption of pseudoephedrine and ephedrine]","author":"Consejo de Salubridad General","year":"2008","journal-title":"Diario Oficial"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2005.01032.x"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02208.x"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2003.00450.x"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2009.06.024"},{"key":"e_1_2_8_28_2","first-page":"105","article-title":"Mexico: systems for epidemiological diagnosis of drug abuse","author":"Medina\u2010Mora M. E.","year":"2003","journal-title":"Bull Narc"},{"key":"e_1_2_8_29_2","volume-title":"National Drug Control Program Actions and Results, First Semester 2005","author":"Procuradur\u00eda General de la Rep\u00fablica (PGR)","year":"2006"},{"key":"e_1_2_8_30_2","volume-title":"National Drug Threat Assessment 2008","author":"National Drug Intelligence Center","year":"2007"},{"key":"e_1_2_8_31_2","volume-title":"Statistical Abstract of the United States, 2010","author":"US Department of Commerce","year":"2010"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.3133\/fs09897"},{"key":"e_1_2_8_33_2","volume-title":"United States\u2013Mexico Border Area, As Delineated by a Shared\u2010Water Resources Perspective","author":"Woodward D.","year":"1996"},{"key":"e_1_2_8_34_2","volume-title":"DEA Briefs and Background, Drugs and Drug Abuse, State Factsheets, Texas","author":"Drug Enforcement Agency","year":"2008"},{"key":"e_1_2_8_35_2","volume-title":"Guidance for the Measurement of Drug Treatment Demand","author":"Global Assessment Programme","year":"2006"},{"key":"e_1_2_8_36_2","unstructured":"Direcci\u00f3n de Investigaci\u00f3n Operativa Epidemiol\u00f3gica.Sistema de Vigilancia Epidemiol\u00f3gica de las Adicciones (SISVEA) Informe 2006 [Epidemiologic Surveillance System of Addictions (SISVEA) 2006 Report]. M\u00e9xico DF: Subsecretar\u00eda de Prevenci\u00f3n y Promoci\u00f3n de la Salud Direcci\u00f3n General de Epidemiolog\u00eda;2006."},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1080\/14659890500246540"},{"key":"e_1_2_8_38_2","first-page":"3","volume-title":"Street\u2010Level Drug Enforcement: Examining the Issues","author":"Kleiman M. A. R.","year":"1988"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2001.96462310.x"},{"key":"e_1_2_8_40_2","volume-title":"The Australian Heroin Drought and Its Implications for Drug Policy. [Crime and Justice Bulletin Number 59]","author":"Weatherburn D.","year":"2001"},{"key":"e_1_2_8_41_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2003.00603.x"},{"key":"e_1_2_8_42_2","first-page":"S5","article-title":"Treatment of patients with substance use disorders (2nd edn)","volume":"164","author":"American Psychiatric Association","year":"2007","journal-title":"Am J Psychiatry"},{"key":"e_1_2_8_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2000.tb05185.x"},{"key":"e_1_2_8_44_2","doi-asserted-by":"publisher","DOI":"10.1080\/10550490500528712"},{"key":"e_1_2_8_45_2","volume-title":"NIDA InfoFacts: Heroin","author":"National Institute on Drug Abuse","year":"2006"},{"key":"e_1_2_8_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4684-3866-6"},{"key":"e_1_2_8_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2005.01160.x"},{"key":"e_1_2_8_48_2","unstructured":"KuriP. L\u00f3pez\u2010GatellH. BojorquezI. CortesM.Update on the epidemiologic surveillance system of addictions (SISVEA) in Mexico: 2007.Epidemiologic Trends in Drug Abuse: Proceedings of the Community Epidemiologic Work Group June 2008. Rockville MD: National Institute on Drug Abuse;2009 p.321\u20138."},{"key":"e_1_2_8_49_2","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1975.10480264"},{"key":"e_1_2_8_50_2","volume-title":"Applied Time Series Analysis for the Social Sciences","author":"McCleary R.","year":"1980"},{"key":"e_1_2_8_51_2","doi-asserted-by":"publisher","DOI":"10.1080\/10934529109375694"},{"key":"e_1_2_8_52_2","doi-asserted-by":"publisher","DOI":"10.2307\/2290724"},{"key":"e_1_2_8_53_2","volume-title":"Forecasting and Time Series Analysis Using the SCA Statistical System","author":"Liu L.\u2010M.","year":"1992"},{"key":"e_1_2_8_54_2","first-page":"2139","article-title":"Controlled drugs and substances act: precursor control regulations","volume":"136","author":"Government of Canada","year":"2002","journal-title":"Canada Gaz"},{"key":"e_1_2_8_55_2","unstructured":"Criminal Intelligence Directorate.Federal and International Operations\u2014Coming into Force of the Precursor Control Regulations. Beginning January 9 2003. Ottawa ON: Royal Canadian Mounted Police;2003."},{"key":"e_1_2_8_56_2","volume-title":"Seventy\u2010Ninth Legislature, 2005. An Act Relating to the Civil and Criminal Consequences of Engaging in Conduct Related to the Manufacture of Methamphetamine and to the Distribution and Retail Sales of Certain Chemical Substances","author":"H. B. No. 164. House of Representatives","year":"2005"},{"key":"e_1_2_8_57_2","volume-title":"Summary of Enactments\u2014Seventy\u2010Ninth Legislature, 2005","author":"H. B. No. 164. House of Representatives","year":"2005"},{"key":"e_1_2_8_58_2","volume-title":"Quasi\u2010Experimentation: Design and Analysis Issues in Field Settings","author":"Cook T. D.","year":"1979"},{"key":"e_1_2_8_59_2","volume-title":"Experimental and Quasi\u2010Experimental Designs for Generalized Causal Inference","author":"Shadish W. R.","year":"2002"},{"key":"e_1_2_8_60_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02502.x"},{"key":"e_1_2_8_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2004.04.006"},{"key":"e_1_2_8_62_2","doi-asserted-by":"publisher","DOI":"10.1525\/msem.2006.22.1.57"},{"key":"e_1_2_8_63_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10609-006-0004-4"},{"key":"e_1_2_8_64_2","doi-asserted-by":"publisher","DOI":"10.1177\/0020852307085737"},{"key":"e_1_2_8_65_2","unstructured":"ConstantineT. A.Statement by Thomas A. Constantine Administrator Drug Enforcement Administration United States Department of Justice. Before the House Subcommittee on the Western Hemisphere House International Relations Committee. Regarding: Drug Control in the Western Hemisphere. June 6 1996. Washington DC: Drug Enforcement Administration;1996."},{"key":"e_1_2_8_66_2","unstructured":"United States Government Accountability Office (GAO).Drug Control: U. S. Assistance has Helped Mexican Counternarcotics Efforts but Tons of Illicit Drugs Continue to Flow into the United States. GAO\u201007\u20101018 August 2007. Washington DC: GAO;2007."},{"key":"e_1_2_8_67_2","first-page":"56","volume-title":"Report of the International Narcotics Control Board for 2008","author":"International Narcotics Control Board","year":"2009"},{"key":"e_1_2_8_68_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2007.02099.x"}],"container-title":["Addiction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1360-0443.2010.03068.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1360-0443.2010.03068.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T15:36:13Z","timestamp":1698766573000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1360-0443.2010.03068.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,5]]},"references-count":67,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["10.1111\/j.1360-0443.2010.03068.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1360-0443.2010.03068.x","archive":["Portico"],"relation":{},"ISSN":["0965-2140","1360-0443"],"issn-type":[{"value":"0965-2140","type":"print"},{"value":"1360-0443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,5]]},"assertion":[{"value":"2010-08-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}